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CASE REPORT
Esophageal metastasis of renal cell 
carcinoma resected by endoscopic submucosal 
dissection: a case report
Ken Ohnita1,2* , Shuntaro Higashi1, Satoshi Hirai1, Ai Kuwahara1, Kana Kakigao1, Suguru Nakashiki1, 
Kenichiro Inoue1, Hirokazu Kurohama3, Masahiro Nakashima3 and Kazuhiko Nakao2 
Abstract 
Background: Esophageal metastasis of renal cell carcinoma (RCC) is extremely rare. We have described herein a case 
of a 59-year-old man with esophageal metastasis of RCC that was endoscopically resected.
Case presentation: The case was a 59-year-old man who had undergone left nephrectomy for renal clear cell 
carcinoma 17 years ago and splenectomy for splenic metastasis 3 years ago. Esophagogastroduodenoscopy (EGD) 
performed 9 years ago revealed a small reddish elevated lesion with a smooth surface in the middle esophagus; this 
lesion increased in size 4 years ago. However, no biopsy was performed. The lesion continued to grow in size and was 
found to have become nodular during the present observation. Biopsy revealed clear cell carcinoma. Endoscopic 
ultrasound (EUS) revealed that the lesion had not invaded the submucosa, and contrast-enhanced computed tomog-
raphy did not reveal any other metastasis. The lesion was successfully removed en bloc via endoscopic submucosal 
dissection (ESD). Pathologically, the tumor was detected in the subepithelium with focal infiltration of the muscularis 
mucosa. It consisted of monotonous cells with small nuclei and a clear cytoplasm. Immunohistological findings indi-
cated that the tumor was a metastasis of RCC. The lateral and vertical margins were noted to be free.
Conclusions: We have presented herein a case of esophageal metastasis of RCC that had progressed over 9 years 
and was then resected en bloc through endoscopic submucosal dissection.
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Background
Esophageal metastasis of RCC is extremely rare. Most 
cases of this disease are detected when the tumor attains 
a large size and rarely when it is small. We have described 
here a case of a 59-year-old man with esophageal metas-
tasis of RCC that had progressed over 9 years and then 
finally removed en bloc by ESD.
Case presentation
The case was a 59-year-old man who had undergone 
left nephrectomy for renal clear cell carcinoma 17 years 
ago and splenectomy for splenic metastasis 3 years ago. 
He then underwent ESD for early gastric cancer 9 years 
ago. At that time, EGD revealed a small reddish elevated 
lesion with a smooth surface in the middle esophagus 
(Fig. 1), and the lesion had increased in size 4 years ago 
during surveillance scope (Fig.  2). However, no biopsy 
was performed because the endoscopist assumed the 
lesion to be a benign polyp. We performed EGD during 
the next follow-up to asses it. The lesion continued to 
increase in size to approximately 10 mm and was found 
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to have become nodular (Fig.  3A). Magnifying narrow 
band imaging endoscopy revealed a dark-green tumor, 
although no intraepithelial papillary capillary loop abnor-
mality was detected (Fig.  3B). We suspected that it was 
a metastasis from the RCC because the polyp was red in 
color, looked like a submucosal tumor, and had increased 
in size. Biopsy revealed clear cell carcinoma. EUS dem-
onstrated that the lesion had not invaded the submucosa 
(Fig.  4), and contrast-enhanced computed tomography 
did not reveal any other metastasis. The lesion was then 
successfully removed en bloc by ESD. Pathologically, 
the tumor (5 × 4  mm) was observed in the subepithe-
lium with a focal infiltration of the muscularis mucosa 
(Fig.  5A). It comprised monotonous cells with small 
nuclei and a clear cytoplasm (Fig. 5B) and was found to 
be immunohistochemically positive for AE1/AE3, CD10 
(Fig. 5C), and vimentin, but negative for chromogranin A, 
synaptophysin, and CD56. The tumor was considered to 
be a metastasis of RCC. The lateral and vertical margins 
were noted to be free. We successfully resected the lesion 
endoscopically and followed it up with observation.
Discussion and conclusion
Metastatic esophageal cancer is a considerably rare 
occurrence. Two mechanisms are believed to be 
involved in metastasis from other organs to the esoph-
agus: (i) the first one is through the direct invasion 
of tissues, such as the lung, trachea/bronchus, thy-
roid, larynx, hypopharynx, and stomach tissues and 
(ii) the second one is through hematogenous/lym-
phogenous invasion of the distant organs, such as the 
uterus or liver [1]. RCC has a tendency to hematoge-
nously metastasize to the lung, bone, or liver. However, 
Fig. 1 EGD disclosed a small reddish elevated lesion whose surface 
was smooth at the middle esophagus
Fig. 2 The lesion increased in size 4 years ago
Fig. 3 A The lesion further increased in size and was found to have become nodular during the present observation. B Magnifying narrow band 
imaging endoscopy revealed a dark-green tumor, but no intraepithelial papillary capillary loop abnormality was detected
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metastasis to the esophagus is extremely rare [1]. Miz-
obuchi et al. reviewed an autopsy data of 1835 patients 
who died of cancer. They reported that 112 (6.1%) cases 
had metastasis to the esophagus and detected com-
mon primary tumor of the lung in 51 patients, of the 
breast in 14 patients, and of the stomach in 13 patients 
[2]. A PubMed search with the keywords “renal cell 
carcinoma,” “renal cancer,” and “esophageal metastasis” 
retrieved only seven studies on esophageal metastasis 
of RCC [1, 3–8]. The endoscopic features of esophageal 
metastasis from RCC were reported with a peduncu-
lated polypoid tumor [1], fragile mass [6], and reddish 
tumor with ulcer [7]. Most cases had presented symp-
toms such as dysphagia, melena, and hematemesis. Our 
case was asymptomatic; thus, we noted that the lesion 
size was small. Patients treated with complete metas-
tasectomy showed better survival and symptom con-
trol than those treated with either incomplete or no 
metastasectomy in a past study [9]. According to the 
National Comprehensive Cancer Network Guidelines 
(version 4, 2018), surgical treatment is indicated when 
the primary tumor site is the kidney and the patient has 
a resectable solitary metastasis [10]. Monteros-Sanchez 
et al. [4] and Izumo et al. [1] underwent esophagectomy 
for metastasis from RCC. If the tumor is unresect-
able, multidisciplinary treatments including radiation 
and chemotherapy with molecular-targeting therapy 
agents, such as tyrosine-kinase inhibitors, are indicated 
[6]. As the metastatic lesion appeared to be intramu-
cosal from the endoscopic ultrasound, we decided to 
perform ESD with adequate margin. Padda et al. diag-
nosed the metastatic RCC by biopsy and accordingly 
performed ESD [8]. However, they did not detect any 
malignant tumor in the ESD specimen. The metastatic 
lesion may have been removed by biopsy. Therefore, 
to our knowledge, our patient represents the first case 
of successful removal by ESD. We could thus conduct 
a complete resection because the lesion remained in 
the muscularis mucosa and was negative for lateral 
and vertical margin. RCC is a slow growing tumor. In 
our case, esophageal metastasis occurred 8  years after 
left nephrectomy. Unfortunately, we could not diagno-
sis the metastasis because we did not perform biopsy 
at that time. However, it is a valuable case that showed 
progression over 9  years. Based on our experience, 
cases of RCC metastasis to the esophagus may increase 
in the future considering that RCC is a slow growing 
tumor, which necessitates development in endoscopic 
diagnosis.
In conclusion, we presented a case of esophageal 
metastasis of RCC that progressed over 9 years and was 
successfully resected en bloc by ESD.
Abbreviations
RCC : Renal cell carcinoma; EGD: Esophagogastroduodenoscopy; ESD: Endo-
scopic submucosal dissection; EUS: Endoscopic ultrasound.
Fig. 4 EUS showing that the lesion (red arrow) did not invade to the 
submucosa (yellow arrow)
Fig. 5 A The tumor (5 × 4 mm) present in the subepithelium with focal infiltration to the muscularis mucosa (arrow) (2 × , hematoxylin–eosin 
stain). B The tumor comprised monotonous cells with small nuclei and a clear cytoplasm (20 × , hematoxylin–eosin stain). C The tumor cells were 
immunohistochemically positive for CD10
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